[Determination of the effects of antineoplastic agents using a canine stomach--evaluation of an antineoplastic polysaccharide, schizophyllan (SPG)].
D000230:Adenocarcinoma / Q000188:drug therapy*; D002288:Adenocarcinoma, Mucinous / Q000188:drug therapy*; D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D005260:Female; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D008297:Male; D010844:Picibanil / Q000627:therapeutic use; D012566:Sizofiran / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000188:drug therapy*
D000972:Antineoplastic Agents, Phytogenic; D006025:Glycosaminoglycans; D010844:Picibanil; D012566:Sizofiran